Does Israel Chemicals Ltd. (ICL) Have Any Gas After Forming This Double Top?

July 18, 2017 - By Louis Casey

The chart of Israel Chemicals Ltd. (ICL) shows a double top with $5.10 target or 8.00 % above today’s $4.72 share price. The 5 months chart pattern indicates low risk for the $6.16 billion company. It was reported on Jul, 18 by If the $5.10 price target is reached, the company will be worth $492.80M more. Double tops are rare but powerful chart patterns.

The stock decreased 1.87% or $0.09 on July 17, reaching $4.72. About shares traded. Israel Chemicals Ltd. (NYSE:ICL) has risen 9.62% since July 18, 2016 and is uptrending. It has underperformed by 7.08% the S&P500.

Israel Chemicals Ltd. (NYSE:ICL) Ratings Coverage

Among 4 analysts covering Israel Chemical (NYSE:ICL), 0 have Buy rating, 1 Sell and 3 Hold. Therefore 0 are positive. Israel Chemical had 5 analyst reports since September 22, 2015 according to SRatingsIntel. The firm has “Hold” rating by BMO Capital Markets given on Thursday, July 6. On Tuesday, September 22 the stock rating was downgraded by Goldman Sachs to “Sell”. As per Tuesday, January 12, the company rating was maintained by Barclays Capital. Jefferies initiated the shares of ICL in report on Thursday, May 25 with “Hold” rating.

More notable recent Israel Chemicals Ltd. (NYSE:ICL) news were published by: which released: “Israel Chemical Ltd. Drops as Official Calls for Dead Sea License Tender” on January 17, 2017, also with their article: “Israel Chemicals Ltd (ICL) PT Raised to $5.25 at Jefferies Following Uralkali …” published on July 14, 2017, published: “Israel Chemicals’ (ICL) CEO Asher Grinbaum on Q4 2016 Results – Earnings Call …” on February 16, 2017. More interesting news about Israel Chemicals Ltd. (NYSE:ICL) were released by: and their article: “An Analysis On Israel Chemicals Ltd.” published on June 22, 2017 as well as‘s news article titled: “Israel Chemicals Reaches Analyst Target Price” with publication date: June 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.